{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:18:10Z","timestamp":1794345490498,"version":"4.9.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017061","name":"CVS Health Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017061","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The potential of virtual care as an alternative to in-person visits is promising, yet its economic impact is insufficiently understood. This evaluation represents an episode-based, cost impact analysis of virtual-first (versus in-person first) care to treat the most prevalent primary care acute conditions among Medicare Advantage (MA) and commercial fully-insured (C-FI) members of a large national health plan in the United States.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Retrospective episodes-of-care and medical claims analyses identified members (<jats:italic>N<\/jats:italic>\u2009=\u2009366,195; MA: 126,363, C-FI: 239,832) with resolved, pre-specified, acute primary care episodes (<jats:italic>N<\/jats:italic>\u2009=\u2009455,231; MA: 141,034, C-FI: 314,197) between 1\/1\/2022\u20136\/30\/2022. Propensity score weighting estimated % difference in healthcare expenditures between virtual-first episodes and an adjusted cohort of in-person-first episodes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Within the MA cohort, 7.6% (range: 0.7\u201324.8%) of episodes utilized virtual-first care with observed cost-of-episode 10\u201324% lower than in-person-first care for 6 of 11 included conditions (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05), including: otolaryngology disease (-24\u2009\u00b1\u20092%), rhinitis (-20\u2009\u00b1\u20094%), gastroenterology disease (-20\u2009\u00b1\u20097%), minor bacterial skin infections (-17\u2009\u00b1\u20097%), sinusitis (-14\u2009\u00b1\u20094%), and bronchitis (-11\u2009\u00b1\u20094%). Within the C-FI cohort, 12.6% (range: 2.8\u201340.4%) of episodes utilized virtual-first care with observed cost-of-episode 9\u201333% lower than in-person-first care (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) for 12 of 16 included conditions (all <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), including: urinary tract infection (-33\u2009\u00b1\u20095%), viral skin infection (-29\u2009\u00b1\u20096%), gastroenterology disease (-27\u2009\u00b1\u20095%), rhinitis (-28\u2009\u00b1\u20095%), otolaryngology disease (-25\u2009\u00b1\u20092%), sinusitis (-25\u2009\u00b1\u20092%), urological disease (-23\u2009\u00b1\u20099%), contact dermatitis (-19\u2009\u00b1\u20095%), viral pneumonia (-17\u2009\u00b1\u200912%), bronchitis (-15\u2009\u00b1\u20094%), fungal skin infection (-11\u2009\u00b1\u20096%), and minor bacterial skin infection (-9\u2009\u00b1\u20097%), and 4\u2009\u00b1\u20092% higher to treat exposure to infectious disease (<jats:italic>P<\/jats:italic>\u2009=\u20090.001). There were no between-group differences in cost-of-episode to treat: skin inflammation (MA &amp; C-FI), urinary tract infection (MA), exposure to infectious disease (MA), fungal skin infection (MA), low back pain (C-FI), or migraine headache (C-FI) (all <jats:italic>P<\/jats:italic>\u2009&gt;\u20090.081).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This real-world study of a large national sample of geographically diverse members demonstrates the potential of virtual-first care to resolve acute conditions at lower cost compared to in-person-first care. The use of episode-based analytical tools enhances the significance of these findings by enabling a proxy for clinical outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12913-025-13154-1","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T16:28:50Z","timestamp":1753806530000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An episode-based cost analysis of virtual-first versus in-person-first care to treat common acute conditions among members of a large national payor"],"prefix":"10.1186","volume":"25","author":[{"given":"Amanda L.","family":"Zaleski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly J.","family":"Thomas Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Junk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur T.","family":"McGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothea J.","family":"Verbrugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristofer","family":"Caya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"issue":"2","key":"13154_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/JXX.0000000000000626","volume":"34","author":"JK Dhaliwal","year":"2021","unstructured":"Dhaliwal JK, Hall TD, LaRue JL, Maynard SE, Pierre PE, Bransby KA. Expansion of telehealth in primary care during the COVID-19 pandemic: benefits and barriers. J Am Assoc Nurse Pract. 2021;34(2):224\u20139.","journal-title":"J Am Assoc Nurse Pract"},{"issue":"1","key":"13154_CR2","first-page":"100","volume":"4","author":"N Khera","year":"2023","unstructured":"Khera N, Knoedler M, Meier SK, TerKonda S, Williams RD, Wittich CM, Coffey JD, Demaerschalk BM. Payment and coverage parity for virtual care and in-person care: how do we get there? Telemed Rep. 2023;4(1):100\u20138.","journal-title":"Telemed Rep"},{"key":"13154_CR3","doi-asserted-by":"publisher","first-page":"e48920","DOI":"10.2196\/48920","volume":"25","author":"K Campbell","year":"2023","unstructured":"Campbell K, Greenfield G, Li E, O\u2019Brien N, Hayhoe B, Beaney T, Majeed A, Neves AL. The impact of virtual consultations on the quality of primary care: systematic review. J Med Internet Res. 2023;25:e48920.","journal-title":"J Med Internet Res"},{"key":"13154_CR4","doi-asserted-by":"crossref","unstructured":"Lachance CC, Severn M, Kim J. Evidence Base for Virtual Primary Care: CADTH Health Technology Review [Internet]. Ottawa (ON); 2023 May. Report No.: HC0062. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594390\/","DOI":"10.51731\/cjht.2023.661"},{"key":"13154_CR5","doi-asserted-by":"publisher","unstructured":"Mold F, Cooke D, Ip A, Roy P, Denton S, Armes J. COVID-19 and beyond: virtual consultations in primary care-reflecting on the evidence base for implementation and ensuring reach: commentary article. BMJ Health Care Inf. 2021;28(1):e100256.\u00a0https:\/\/doi.org\/10.1136\/bmjhci-2020-100256","DOI":"10.1136\/bmjhci-2020-100256"},{"key":"13154_CR6","doi-asserted-by":"publisher","first-page":"205031211984020","DOI":"10.1177\/2050312119840200","volume":"7","author":"C Peterson","year":"2019","unstructured":"Peterson C, Grosse SD, Dunn A. A practical guide to episode groupers for cost-of-illness analysis in health services research. SAGE Open Med. 2019;7:2050312119840200.","journal-title":"SAGE Open Med"},{"issue":"23","key":"13154_CR7","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1001\/jama.2020.7819","volume":"323","author":"LE Thomas","year":"2020","unstructured":"Thomas LE, Li F, Pencina MJ. Overlap weighting: A propensity score method that mimics attributes of a randomized clinical trial. JAMA. 2020;323(23):2417\u20138.","journal-title":"JAMA"},{"key":"13154_CR8","unstructured":"Center for Disease Control and Prevention. COVID Data Tracker. https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home."},{"key":"13154_CR9","doi-asserted-by":"publisher","first-page":"108523","DOI":"10.1016\/j.pharmthera.2023.108523","volume":"250","author":"G Juhasz","year":"2023","unstructured":"Juhasz G, Gecse K, Baksa D. Towards precision medicine in migraine: recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response. Pharmacol Ther. 2023;250:108523.","journal-title":"Pharmacol Ther"},{"issue":"12","key":"13154_CR10","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.spinee.2021.05.019","volume":"21","author":"MC Jin","year":"2021","unstructured":"Jin MC, Azad TD, Fatemi P, Ho AL, Vail D, Zhang Y, Feng AY, Kim LH, Bentley JP, Stienen MN, et al. Defining and describing treatment heterogeneity in new-onset idiopathic lower back and extremity pain through reconstruction of longitudinal care sequences. Spine J. 2021;21(12):1993\u20132002.","journal-title":"Spine J"},{"issue":"5","key":"13154_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","volume":"6","author":"MA Brookhart","year":"2013","unstructured":"Brookhart MA, Wyss R, Layton JB, Sturmer T. Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes. 2013;6(5):604\u201311.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"13154_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.3389\/fphar.2019.00973","volume":"10","author":"MS Ali","year":"2019","unstructured":"Ali MS, Prieto-Alhambra D, Lopes LC, Ramos D, Bispo N, Ichihara MY, Pescarini JM, Williamson E, Fiaccone RL, Barreto ML, et al. Propensity score methods in health technology assessment: principles, extended applications, and recent advances. Front Pharmacol. 2019;10:973.","journal-title":"Front Pharmacol"},{"key":"13154_CR13","doi-asserted-by":"publisher","first-page":"e66499","DOI":"10.2196\/66499","volume":"27","author":"I Peles","year":"2025","unstructured":"Peles I, Novack L, Peleg S, Levanon E, Gordon M, Abayev M, Novack V, Codish S. Evaluating clinical outcomes and physician adoption of telemedicine for chronic disease management: Population-Based retrospective cohort study. J Med Internet Res. 2025;27:e66499.","journal-title":"J Med Internet Res"},{"issue":"9","key":"13154_CR14","doi-asserted-by":"publisher","first-page":"e2233267","DOI":"10.1001\/jamanetworkopen.2022.33267","volume":"5","author":"DJ Baughman","year":"2022","unstructured":"Baughman DJ, Jabbarpour Y, Westfall JM, Jetty A, Zain A, Baughman K, Pollak B, Waheed A. Comparison of quality performance measures for patients receiving In-Person vs telemedicine primary care in a large integrated health system. JAMA Netw Open. 2022;5(9):e2233267.","journal-title":"JAMA Netw Open"},{"issue":"6 Spec No","key":"13154_CR15","first-page":"SP430","volume":"30","author":"M Noble","year":"2024","unstructured":"Noble M, Chen F, Linke S, Dall TM, Napoleone J. Modeling the economic value of cardiometabolic virtual-first care programs. Am J Manag Care. 2024;30(6 Spec No):SP430\u20136.","journal-title":"Am J Manag Care"},{"issue":"5","key":"13154_CR16","first-page":"e59569","volume":"16","author":"BA Farford","year":"2024","unstructured":"Farford BA, Bulbarelli EM, Ricketts I, Nath S, Ahuja AS, Keith J. Accuracy of telehealth visits for acute care needs in family medicine. Cureus. 2024;16(5):e59569.","journal-title":"Cureus"},{"issue":"10","key":"13154_CR17","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.7326\/M23-1335","volume":"176","author":"M Reed","year":"2023","unstructured":"Reed M, Huang J, Somers M, Hsueh L, Graetz I, Millman A, Muelly E, Gopalan A. Telemedicine versus In-Person primary care: treatment and Follow-up visits. Ann Intern Med. 2023;176(10):1349\u201357.","journal-title":"Ann Intern Med"},{"issue":"6","key":"13154_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jama.2021.25181","volume":"327","author":"S Nundy","year":"2022","unstructured":"Nundy S, Cooper LA, Mate KS. The quintuple aim for health care improvement: A new imperative to advance health equity. JAMA. 2022;327(6):521\u20132.","journal-title":"JAMA"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13154-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13154-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13154-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:42:59Z","timestamp":1757320979000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-025-13154-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13154"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13154-1","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and determined to be exempt by the Sterling Institutional Review Board (#11260) under 45 CFR 46.104(d)(4). Consent to participate was waived by the Institutional Review Board as the study involved administrative review of deidentified records and no interaction with participants and no direct impact on participant\u2019s rights, welfare, or clinical care. In addition, a waiver of Health Insurance Portability and Accountability Act authorization for the use and disclosure of aggregated, deidentified member data was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are employees of CVS Health\u00ae Corporation. ALZ, KJTC, CJ, DV, and KC own stock and\/or equity with CVS Health Corporation. There are no additional conflicts germane to this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"994"}}